Bristol-Myers Squibb Underwriting Agreements
9 Contracts & Agreements
- Underwriting Agreement, dated February 14, 2024, among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on February 22, 2024)
- Underwriting Agreement, dated October 30, 2023, by and among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on November 13, 2023)
- Underwriting Agreement, dated February 15, 2022, among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on February 22, 2022)
- Underwriting Agreement, dated November 9, 2020, among Bristol-Myers Squibb Company and the underwriters named therein (Filed With SEC on November 13, 2020)
- UNDERWRITING AGREEMENT, dated as of February 22, 2017 Bristol-Myers Squibb Company 1.600% Notes due 2019 3.250% Notes due 2027 (Filed With SEC on February 27, 2017)
- UNDERWRITING AGREEMENT, dated as of April 29, 2015 Bristol-Myers Squibb Company 1.000% Notes due 2025 1.750% Notes due 2035 (Filed With SEC on May 5, 2015)
- UNDERWRITING AGREEMENT, dated as of October 24, 2013 Bristol-Myers Squibb Company 1.750% Notes due 2019 3.250% Notes due 2023 4.500% Notes due 2044 (Filed With SEC on October 31, 2013)
- Bristol-Myers Squibb Company 0.875% Notes due 2017 2.000% Notes due 2022 3.250% Notes due 2042 Underwriting Agreement (Filed With SEC on July 31, 2012)
- Bristol-Myers Squibb Company 5.875% Notes due 2036 Underwriting Agreement (Filed With SEC on November 27, 2006)
